A study on nude mice with subcutaneous human HCT-116 colon tumor xenografts treated with everolimus observed the direct inhibition of tumor growth and a dose-dependent decline in phospho-S6 kinase levels, an mTOR target [25]. This evidence concerns the gene MTOR and colonic neoplasm.